The FDA has granted approval to Aurobindo Pharma Limited for its generic Tramadol Hydrochloride oral product, marking a new competitive entry into the opioid analgesic market. This ANDA approval is expected to broaden manufacturer portfolios and drive price competition for the widely prescribed opioid combination therapy.